ADIM
VIAV icon

Alpha DNA Investment Management’s Viavi Solutions VIAV Stock Holding History

Alpha DNA Investment Management’s Portfolio VIAV Stock Details VIAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-251
Closed -$3K – 636
2021
Q1 		$3K Buy
251
+71
+39% +$1.15K ﹤0.01% 522
2020
Q4 		$2K Buy
+180
New +$2.39K ﹤0.01% 492

Other funds holding VIAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alpha DNA Investment Management's VIAV Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Viavi Solutions (VIAV) in Q2 2021, closing a stake of 251 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in VIAV in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 291 funds tracked by Wall St. Rank hold VIAV as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Viavi Solutions position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 251 Viavi Solutions shares in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in Viavi Solutions in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Viavi Solutions position peaked at $3K in Q1 2021.
  • 291 funds tracked by Wall St. Rank held Viavi Solutions as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.